Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation-Reference-Cited by-同舟云学术

Effect of 15-mg Edoxaban on Clinical Outcomes in 3 Age Strata in Older Patients With Atrial Fibrillation

Published:2022-06-01 Issue:6 Volume:7 Page:583
ISSN:2380-6583
Container-title:JAMA Cardiology
language:en
Short-container-title:JAMA Cardiol

Author:

Kuroda Masaru¹,Tamiya Eiji²,Nose Takahisa³,Ogimoto Akiyoshi⁴,Taura Junki⁵,Imamura Yuki⁵,Fukuzawa Masayuki⁵,Hayashi Takuya⁶,Akao Masaharu⁷,Yamashita Takeshi⁸,Lip Gregory Y. H.⁹¹⁰,Okumura Ken¹¹

Affiliation:

1. Department of Cardiology, Akashi Medical Center, Hyogo, Japan

2. Department of Cardiology, Koto Hospital, Tokyo, Japan

3. Department of Cardiology, Nose Hospital, Hyogo, Japan

4. Division of Cardiology, Uwajima City Hospital, Ehime, Japan

5. Clinical Development Department III, Development Function, Research and Development Division, Daiichi Sankyo, Tokyo, Japan

6. The Data Intelligence Group, Data Intelligence Department, Digital Transformation Management Division, Daiichi Sankyo, Tokyo, Japan

7. Department of Cardiology, National Hospital Organization Kyoto Medical Center, Kyoto, Japan

8. The Cardiovascular Institute, Tokyo, Japan

9. The Liverpool Centre for Cardiovascular Science, University of Liverpool and Liverpool Heart and Chest Hospital, Liverpool, United Kingdom

10. Aalborg Thrombosis Research Unit, Department of Clinical Medicine, Aalborg University, Aalborg, Denmark

11. Division of Cardiology, Saiseikai Kumamoto Hospital, Kumamoto, Japan

Publisher

American Medical Association (AMA)

Subject

Cardiology and Cardiovascular Medicine

Link

https://jamanetwork.com/journals/jamacardiology/articlepdf/2790738/jamacardiology_kuroda_2022_oi_220010_1654532435.27494.pdf

Reference19 articles.

1. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.;Go;JAMA,2001

2. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.;Wolf;Stroke,1991

3. 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines and the Heart Rhythm Society.;January;J Am Coll Cardiol,2019

4. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS.;Kirchhof;Eur Heart J,2016

5. Inappropriate use of oral anticoagulants for patients with atrial fibrillation.;Akao;Circ J,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prophylactic Effect of Aspirin and Other Medicine on Cerebral Infarction for Patients with Cardiovascular Diseases Risk Factors: A Systemic Review and Meta-Analysis;Cardiology in Review;2024-09-10

2. Effectiveness and Safety of Different Oral Anticoagulants with P-glycoprotein/ CYP3A4 Inhibitors: A Network Meta-analysis;Current Pharmaceutical Design;2024-04

3. Efficacy and Safety of Low‐Dose Edoxaban by Body Weight in Very Elderly Patients With Atrial Fibrillation: A Subanalysis of the Randomized ELDERCARE‐AF Trial;Journal of the American Heart Association;2024-02-06

4. Efficacy and Safety of Direct Oral Anticoagulants for Stroke Prevention in Older Patients With Atrial Fibrillation: A Network Meta‐Analysis of Randomized Controlled Trials;Journal of the American Heart Association;2023-12-05

5. JAMA Cardiology—The Year in Review, 2022;JAMA Cardiology;2023-05-01